Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase NA 1Phase 2 1

Status

Completed 4Unknown 1Terminated 1

Sponsor Class

OTHER_GOV 1OTHER 1NIH 1NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 2Breast 2

Conditions

Prostatic Neoplasms 2Osteoporosis 2Hypogonadism 2Breast Neoplasms 2

Interventions

Cyclophosphamide 299Cisplatin 298Paclitaxel 257Radiotherapy 255Fluorouracil 234Carboplatin 234Docetaxel 230Doxorubicin 216Dexamethasone 166Gemcitabine 156Vincristine 147Etoposide 136Leucovorin 133Capecitabine 129Bevacizumab 129Prednisone 125Rituximab 118Methotrexate 118Cytarabine 110Filgrastim 99Trastuzumab 97Oxaliplatin 96pembrolizumab 83Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Daunorubicin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Completed × Alendronate × Clear all
NCT00354302 2020-04-02

Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial

Canadian Cancer Trials Group

Phase 3 Completed
497 enrolled
Breast

Breast Neoplasms, Osteoporosis

NCT00177619 2014-02-11

Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation Therapy (POP Study)

University of Pittsburgh

Phase 3 Completed
120 enrolled
Genitourinary

Hypogonadism, Prostatic Neoplasms

NCT00122356 2013-03-13

BATMAN

Barwon Health

Phase 3 Completed
303 enrolled
Breast

Breast Neoplasms

NCT00048841 2010-03-02

Prevention of Osteoporosis in Men With Prostate Cancer

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Phase 3 Completed
112 enrolled
Genitourinary

Hypogonadism, Osteoporosis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡